[New drugs in type 2 diabetes mellitus therapy]
- PMID: 24007229
[New drugs in type 2 diabetes mellitus therapy]
Abstract
The objective in developing a new type 2 diabetes therapy is to achieve greater safety and better efficacy. Newly registered drugs include lixisenatide, QW exenatide, dapagliflozin and insulin degludec. Once weekly gliptins and other substances are under development.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
